Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson's disease

被引:36
作者
Chen, Hwei-Hsien [1 ,2 ]
Chang, Pei-Chi [2 ]
Chen, Chinpiao [3 ]
Chan, Ming-Huan [4 ]
机构
[1] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan
[2] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan
[3] Natl Dong Hwa Univ, Dept Chem, Hualien, Taiwan
[4] Natl Chengchi Univ, Inst Neurosci, Res Ctr Mind Brain & Learning, Taipei, Taiwan
关键词
Apomorphine; Honokiol; 6-Hydroxydopamine; Parkinson's disease; Tyrosine hydroxylase; NITRIC-OXIDE SYNTHASE; L-DOPA; 6-OHDA; 6-HYDROXYDOPAMINE; NEUROPROTECTION; PATHOGENESIS; INVOLVEMENT; SYMPTOMS; MAGNOLOL; RATS;
D O I
10.1016/j.pharep.2018.01.003
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Background: Parkinson's disease (PD) is a progressive and profound movement disorder resulting from neurodegeneration in the nigrostriatal dopaminergic system, but current treatment neither cures nor stops PD from advancing. Based on the ability to suppress oxidative stress, excitotoxicity, and neuroinflammation, the potential of honokiol as a novel neuroprotective agent for PD treatment was determined. Methods: The hemi-parkinsonian model was used to investigate the protective and therapeutic effects of honokiol on motor dysfunctions and dopaminergic neurodegeneration in mice, with a single unilateral striatal injection of 6-hydroxydopamine (6-OHDA). Results: One day after 6-OHDA-induced lesion, the mice exhibited spontaneous ipsilateral turning, motor imbalance, and incoordination which were mild with a single administration of honokiol prior to 6-OHDA injection. Thereafter, honokiol was continually applied daily for 14 days, which ameliorated apomorphine-induced contralateral rotation and reduced the loss of tyrosine hydroxylase-immunoreactive (TH-ir) fibers in the lesioned striatum. In addition, honokiol posttreatment, beginning on day 8 after 6-OHDA lesion, for 14 days efficiently rescued motor deficits and recovered the TH-ir neuronal loss in both the lesioned striatum and the ipsilateral substantia nigra. The 6-OHDA-induced increases in nigrostriatal expression of inducible nitric oxide synthase (iNOS) and decreases in that of nNOS were also reversed by honokiol posttreatment. Conclusions: These findings revealed that honokiol has both protective and therapeutic effects on motor impairments and dopaminergic progressive damage, at least in part through modulation of NOS signaling, in 6-OHDA-lesioned mice. Honokiol may represent a potential therapeutic candidate for the management of motor symptoms and neurodegeneration in PD. (C) 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.
引用
收藏
页码:668 / 676
页数:9
相关论文
共 31 条
[1]
Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice [J].
Alvarez-Fischer, Daniel ;
Henze, Carmen ;
Strenzke, Corinna ;
Westrich, Jan ;
Ferger, Boris ;
Hoeglinger, Guenter U. ;
Oertel, Wolfgang H. ;
Hartmann, Andreas .
EXPERIMENTAL NEUROLOGY, 2008, 210 (01) :182-193
[2]
Role of Nitric Oxide Synthases in Parkinson's Disease: A Review on the Antioxidant and Anti-inflammatory Activity of Polyphenols [J].
Aquilano, Katia ;
Baldelli, Sara ;
Rotilio, Giuseppe ;
Ciriolo, Maria Rosa .
NEUROCHEMICAL RESEARCH, 2008, 33 (12) :2416-2426
[3]
Protective and Restorative Effects of Magnolol on Neurotoxicity in Mice with 6-Hydroxydopamine-Induced Hemiparkinsonism [J].
Chen, Hwei-Hsien ;
Lin, Shiau-Chin ;
Chan, Ming-Huan .
NEURODEGENERATIVE DISEASES, 2011, 8 (05) :364-374
[4]
Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells [J].
Chuang, Dennis Y. ;
Chan, Ming-Huan ;
Zong, Yijia ;
Sheng, Wenwen ;
He, Yan ;
Jiang, Jing Hua ;
Simonyi, Agnes ;
Gu, Zezong ;
Fritsche, Kevin L. ;
Cui, Jiankun ;
Lee, James C. ;
Folk, William R. ;
Lubahn, Dennis B. ;
Sun, Albert Y. ;
Sun, Grace Y. .
JOURNAL OF NEUROINFLAMMATION, 2013, 10
[5]
Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease [J].
Clarke, CE .
LANCET NEUROLOGY, 2004, 3 (08) :466-474
[6]
Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: The effects of chronic treatment with L-DOPA and the nitric oxide donor, molsidomine [J].
Czarnecka, Anna ;
Lenda, Tomasz ;
Domin, Helena ;
Konieczny, Jolanta ;
Smialowska, Maria ;
Lorenc-Koci, Elibieta .
BRAIN RESEARCH, 2013, 1541 :92-105
[7]
Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson's disease [J].
Faulkner, Michele A. .
EXPERT OPINION ON DRUG SAFETY, 2014, 13 (08) :1055-1069
[8]
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease [J].
Fleming, Sheila M. ;
Ekhator, Osunde R. ;
Ghisays, Valentins .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (76)
[9]
Protective Effects of Lycium barbarum Polysaccharide on 6-OHDA-Induced Apoptosis in PC12 Cells through the ROS-NO Pathway [J].
Gao, Kai ;
Liu, Meiyou ;
Cao, Jinyi ;
Yao, Minna ;
Lu, Yunyang ;
Li, Jiankang ;
Zhu, Xiaohe ;
Yang, Zhifu ;
Wen, Aidong .
MOLECULES, 2015, 20 (01) :293-308
[10]
HAAVIK J, 1998, MOL NEUROBIOL, V16, P285